486 related articles for article (PubMed ID: 17554117)
21. Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.
Ignaczak TF; Sipe JD; Linke FP; Glenner GG
J Lab Clin Med; 1977 May; 89(5):1092-1104. PubMed ID: 404372
[TBL] [Abstract][Full Text] [Related]
22. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
23. Amyloidosis and rheumatoid arthritis.
Husby G
Clin Exp Rheumatol; 1985; 3(2):173-80. PubMed ID: 3893817
[TBL] [Abstract][Full Text] [Related]
24. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
25. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
[TBL] [Abstract][Full Text] [Related]
27. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
28. Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist.
Pastore S; Paloni G; Caorsi R; Ronfani L; Taddio A; Lepore L;
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S63-6. PubMed ID: 25069027
[TBL] [Abstract][Full Text] [Related]
29. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
30. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T
Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528
[TBL] [Abstract][Full Text] [Related]
31. [A review for recent advances in AA amyloid research and therapeutic approach to AA amyloidosis complicating rheumatoid arthritis].
Tamura H; Hasegawa K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):35-42. PubMed ID: 19252376
[TBL] [Abstract][Full Text] [Related]
32. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
Gursky O
Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
[TBL] [Abstract][Full Text] [Related]
34. [Serum amyloid a protein concentrations in patients with familial Mediterranean fever].
Dzhndoian ZT
Georgian Med News; 2011 Dec; (201):48-51. PubMed ID: 22306501
[TBL] [Abstract][Full Text] [Related]
35. Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis.
Ray A; Shakya A; Kumar D; Benson MD; Ray BK
J Immunol; 2006 Aug; 177(4):2601-9. PubMed ID: 16888022
[TBL] [Abstract][Full Text] [Related]
36. From renal amyloid deposits to the identification of the culprit genes.
Pirson Y
J Nephrol; 2003; 16(3):427-30. PubMed ID: 12832746
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
Maury CP; Wegelius O
Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease and systemic AA amyloidosis.
Sattianayagam PT; Gillmore JD; Pinney JH; Gibbs SD; Wechalekar AD; Gilbertson JA; Rowczenio D; Hawkins PN; Lachmann HJ
Dig Dis Sci; 2013 Jun; 58(6):1689-97. PubMed ID: 23371008
[TBL] [Abstract][Full Text] [Related]
39. AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases.
Lachmann HJ; Goodman HJ; Andrews PA; Gallagher H; Marsh J; Breuer S; Rowczenio DM; Bybee A; Hawkins PN
Arthritis Rheum; 2006 Jun; 54(6):2010-4. PubMed ID: 16732551
[TBL] [Abstract][Full Text] [Related]
40. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
